AMJ Financial Wealth Management Acquires Shares of 425 UnitedHealth Group Incorporated (NYSE:UNH)

AMJ Financial Wealth Management acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) during the 3rd quarter, Holdings Channel reports. The institutional investor acquired 425 shares of the healthcare conglomerate’s stock, valued at approximately $215,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Virtus ETF Advisers LLC bought a new stake in UnitedHealth Group in the second quarter valued at approximately $718,000. Octavia Wealth Advisors LLC increased its stake in shares of UnitedHealth Group by 8.8% during the second quarter. Octavia Wealth Advisors LLC now owns 740 shares of the healthcare conglomerate’s stock worth $380,000 after purchasing an additional 60 shares during the period. Arcus Capital Partners LLC increased its stake in shares of UnitedHealth Group by 40.1% during the third quarter. Arcus Capital Partners LLC now owns 2,456 shares of the healthcare conglomerate’s stock worth $1,241,000 after purchasing an additional 703 shares during the period. Great Valley Advisor Group Inc. increased its stake in shares of UnitedHealth Group by 41.8% during the second quarter. Great Valley Advisor Group Inc. now owns 26,614 shares of the healthcare conglomerate’s stock worth $13,670,000 after purchasing an additional 7,851 shares during the period. Finally, Crumly & Associates Inc. increased its stake in shares of UnitedHealth Group by 2.5% during the second quarter. Crumly & Associates Inc. now owns 1,578 shares of the healthcare conglomerate’s stock worth $810,000 after purchasing an additional 38 shares during the period. Institutional investors own 86.31% of the company’s stock.

UnitedHealth Group Trading Down 0.4 %

NYSE UNH opened at $489.75 on Wednesday. The company has a quick ratio of 0.82, a current ratio of 0.77 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a twelve month low of $445.73 and a twelve month high of $558.10. The company has a market cap of $457.60 billion, a price-to-earnings ratio of 23.20, a price-to-earnings-growth ratio of 1.36 and a beta of 0.73. The business’s fifty day moving average is $518.45 and its 200 day moving average is $524.08.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its earnings results on Friday, January 13th. The healthcare conglomerate reported $5.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.17 by $0.17. The business had revenue of $82.79 billion during the quarter, compared to analyst estimates of $82.53 billion. UnitedHealth Group had a return on equity of 27.04% and a net margin of 6.21%. UnitedHealth Group’s revenue for the quarter was up 12.3% compared to the same quarter last year. During the same period last year, the company earned $4.48 EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 24.9 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 13th. Stockholders of record on Monday, December 5th were given a $1.65 dividend. This represents a $6.60 annualized dividend and a dividend yield of 1.35%. The ex-dividend date was Friday, December 2nd. UnitedHealth Group’s dividend payout ratio (DPR) is presently 31.15%.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. Raymond James lowered UnitedHealth Group from a “strong-buy” rating to an “outperform” rating and set a $615.00 target price on the stock. in a research note on Monday, November 21st. SVB Leerink reduced their price target on UnitedHealth Group from $625.00 to $618.00 and set an “outperform” rating on the stock in a research report on Monday, October 17th. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $615.00 to $617.00 and gave the stock a “buy” rating in a research report on Tuesday. UBS Group reduced their price target on UnitedHealth Group from $590.00 to $550.00 and set a “neutral” rating on the stock in a research report on Wednesday, January 18th. Finally, Credit Suisse Group raised their target price on UnitedHealth Group from $590.00 to $610.00 and gave the company an “outperform” rating in a report on Wednesday, December 7th. Three equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $599.39.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 450 shares of UnitedHealth Group stock in a transaction dated Wednesday, December 7th. The stock was sold at an average price of $542.30, for a total value of $244,035.00. Following the completion of the transaction, the executive vice president now directly owns 8,736 shares of the company’s stock, valued at approximately $4,737,532.80. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.40% of the company’s stock.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.